MOORE CAPITAL MANAGEMENT, LP - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 48 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,659,000
+4.4%
105,0000.0%0.03%
+14.8%
Q2 2023$1,589,700
+4.4%
105,0000.0%0.03%
-15.6%
Q1 2023$1,522,500
+7.2%
105,0000.0%0.03%
-5.9%
Q4 2022$1,419,600
-14.2%
105,0000.0%0.03%
-12.8%
Q3 2022$1,655,000
+29.4%
105,0000.0%0.04%
+14.7%
Q2 2022$1,279,000
+29.7%
105,0000.0%0.03%
+36.0%
Q1 2022$986,000
-45.2%
105,0000.0%0.02%
-30.6%
Q4 2021$1,798,000105,0000.04%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$69,750,00026.57%
5AM Venture Management, LLC 4,408,379$69,476,00013.31%
72 Investment Holdings, LLC 509,023$8,022,0006.36%
TCG Crossover Management, LLC 642,189$10,121,0003.04%
StepStone Group LP 761,277$11,998,0001.71%
Nan Fung Group Holdings Ltd 141,593$2,232,0001.42%
Redmile Group, LLC 1,954,419$30,802,0001.20%
Baker Brothers Advisors 4,865,819$76,685,0000.50%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,655,0000.04%
Laurion Capital Management LP 199,066$3,137,0000.02%
View complete list of ENTRADA THERAPEUTICS INC shareholders